PROTAC HDAC6 degrader 1

Modify Date: 2024-04-06 01:00:02

PROTAC HDAC6 degrader 1 Structure
PROTAC HDAC6 degrader 1 structure
Common Name PROTAC HDAC6 degrader 1
CAS Number 2785404-76-2 Molecular Weight 734.80
Density N/A Boiling Point N/A
Molecular Formula C37H46N6O10 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of PROTAC HDAC6 degrader 1


PROTAC HDAC6 degrader (Compound A6) is a potent and selective PROTAC HDAC6 degrader with a DC50 of 3.5 nM. PROTAC HDAC6 degrader shows promising antiproliferative activity via inducing apoptosis in myeloid leukemia cell lines[1].

 Names

Name PROTAC HDAC6 degrader 1

 PROTAC HDAC6 degrader 1 Biological Activity

Description PROTAC HDAC6 degrader (Compound A6) is a potent and selective PROTAC HDAC6 degrader with a DC50 of 3.5 nM. PROTAC HDAC6 degrader shows promising antiproliferative activity via inducing apoptosis in myeloid leukemia cell lines[1].
Related Catalog
Target

HDAC6:3.5 nM (DC50)

HDAC6:4.86 nM (IC50)

HDAC1:0.1 μM (IC50)

In Vitro PROTAC HDAC6 degrader (Compound A6) (0.1-10 μM; 6 h) does not degrade HDAC1 but displays inhibitory activity toward HDAC1. PROTAC HDAC6 degrader demonstrates potent HDAC6 degradation as well as hyperacetylation of α-tubulin in U266 and HL-60 cells, confirming that the activity is not restricted to leukemia cell lines[1]. PROTAC HDAC6 degrader (0.5-50 μM) inhibits leukemia cells viability with log IC50 values of 1.2-1.7 μM[1]. PROTAC HDAC6 degrader (8-24 μM; 48 h) induces MOLM13 cell apoptosis and arrests cell cycle at sub-G1 phase[1]. Western Blot Analysis[1] Cell Line: HL-60 cells Concentration: 100 nM, 1 μM, 10 μM Incubation Time: 6 h Result: Degraded HDAC6 but not HDAC1. Induced hyperacetylation of α-tubulin and caused hyperacetylation of histone H3. Cell Viability Assay[1] Cell Line: Acute myeloid leukemia or AML (HL-60, Kasumi, THP-1, HL-60, SKNO1, and MOLM13) and B-cell acute lymphoblastic leukemia or B-ALL (REH and 697) Concentration: 0.5-50 μM Incubation Time: 72 h Result: Inhibited cell viability with log IC50 values of 1.2-1.7 μM. Apoptosis Analysis[1] Cell Line: MOLM13 Concentration: 8, 16 and 24 μM Incubation Time: 48 h Result: Induced caspase 3/7-dependent apoptosis in dose-dependent fashion. Cell Cycle Analysis[1] Cell Line: MOLM13 Concentration: 8, 16 and 24 μM Incubation Time: 48 h Result: Induced a dose-dependent increase in the sub-G1 fraction with a concomitant reduction of cell population in G2/M phase.
References

[1]. Sinatra L, et al. Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity. J Med Chem. 2022 Dec 22;65(24):16860-16878.  

 Chemical & Physical Properties

Molecular Formula C37H46N6O10
Molecular Weight 734.80
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.